Vivo Bio Tech Ltd Performance
Open
43.2
Traded Value (Cr)
1.49 L
Prev. Close
41.46
VWAP
41.83
Volume
3,499
Face Value
10
Vivo Bio Tech Ltd Fundamentals
Vivo Bio Tech Ltd Financials
Resistance and Support
₹43.60
PIVOT
Resistance | |
---|---|
First Resistance | ₹45.193 |
Second Resistance | ₹46.897 |
Third Resistance | ₹48.493 |
Support | |
---|---|
First Resistance | ₹41.893 |
Second Resistance | ₹40.297 |
Third Resistance | ₹38.593 |
RSI | 30.135 |
MACD | -0.842 |
ADX | 21.779 |
CCI | -263.759 |
Delivery and Volume
About Vivo Bio Tech Ltd
Vivo Bio Tech is a full service CRO offering drug development & discovery services to pharmaceutical & biotech companies world-wide in accordance with OECD, AAALAC & IND guidelines. The company offers services in the areas of In vitro, In vivo, toxicity studies, pharmacological investigations, pharmacokinetics & toxicokinetic studies etc. Our experienced & talented scientists offer advice on defining drug development paths tailored to specific molecules. Tailored and dedicated to our clients, we distinguish your development plan is as superlative as the products you bring to our testing facilities. The Biologic Research Services group at Vivo Bio Tech offers a complete line of protein services, including gene synthesis, cloning, expression and purification of recombinant proteins and monoclonal antibodies. Our scientists will team up with you to develop solution for the most difficult to deal products including purification of untagged & poorly expressed proteins. In-vitro Services offers solutions for pharmacologic, toxicological & bioanalytical investigations in drug discovery & development. Critical investigations like bacterial reverse mutation assays, chromosomal aberration, and micronucleus are specialty services by our scientists. The In-vivo Services group at Vivo Bio Tech provides both non-regulatory and regulatory IND enabling preclinical development services. We are capable of screening & evaluating molecules for various pharmacological & therapeutic properties. Specifically for oncology, our scientists can provide design & development of xenograft models for evaluation of anti-cancer agents. Further, our scientists can customize in-vivo DMPK studies to help profile your drug candidate in both rodent and non-rodent animal models. Vivo Bio has partnered with Taconic for sourcing foundation and expansion colonies of the animal models and have started in-house breeding of Specific Pathogen Free rodents.
Managing Director
Founded
1987
NSE Symbol
Vivo Bio Tech Ltd Management
Name | Designation |
---|---|
Kalyan Ram Mangipudi | Whole-time Director |
Alangudi Sankaranarayanan | Whole-time Director |
K Sunder | Chairman & Independent Directo |
Hariharan Ravindran | Independent Director |
Kunda Kalpana | Independent Director |
Karopadi Shivanand Nayak | Director |
K Sri Kalyan | Whole Time Director & CFO |
Shyam Sunder Tipparaju | Additional Director |